European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like The prebiotic effects of omega-3 fatty acid supplementation September 8, 2021 Synbiotic Containing HMOs Evaluated for Dysbiosis September 8, 2023 Prebiotic claim awarded for inulin and oligofructose in Indonesia May 19, 2021